A tale of coronary artery disease and myocardial infarction.
暂无分享,去创建一个
[1] J. LeLorier,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[2] Kenneth R Chien,et al. Regeneration next: toward heart stem cell therapeutics. , 2009, Cell stem cell.
[3] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[4] A. Endo,et al. The discovery and development of HMG-CoA reductase inhibitors. , 1992, Journal of lipid research.
[5] Børge G Nordestgaard,et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial , 2009, The Lancet.
[6] Wojciech Zareba,et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.
[7] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[8] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.
[9] C. Mahaim. [Catheterization of the right heart]. , 1961, Praxis.
[10] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[11] Richard M Weinshilboum,et al. Genomics and drug response. , 2011, The New England journal of medicine.
[12] T. Sanborn,et al. The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. , 1995, American heart journal.
[13] J. Hare,et al. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.
[14] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[15] W. Porter. On the Results of Ligation of the Coronary Arteries , 1893, The Journal of physiology.
[16] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[17] M. Pfeffer,et al. C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.
[18] Stephen Colagiuri,et al. Grand challenges in chronic non-communicable diseases , 2007, Nature.
[19] J. Covell,et al. Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.
[20] J. Burkhardt,et al. Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure , 2007, Circulation.
[21] J. Herrick. CLINICAL FEATURES OF SUDDEN OBSTRUCTION OF THE CORONARY ARTERIES , 1912 .
[22] Bridget B. Kelly,et al. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health , 2010 .
[23] J. Warren. Remarks on angina pectoris. , 1962, The New England journal of medicine.
[24] J A McWilliam,et al. Cardiac Failure and Sudden Death , 1889, British medical journal.
[25] E. Antman,et al. Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.
[26] S. Sarić. [Catheterization of the right heart]. , 1955, Lijecnicki vjesnik.
[27] E. Nabel. Cardiovascular disease , 2000, Nature Biotechnology.
[28] T. Farag. Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.
[29] C. Peterson. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: Grines CL, Browne KF, Marco J, et al. N Engl J Med 328:673–679 Mar 1993 , 1993 .
[30] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[31] J. Goldstein,et al. History of Discovery The LDL Receptor , 2009 .
[32] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[33] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[34] T. Lancet. The Global Alliance for Chronic Diseases , 2009, The Lancet.
[35] D. Julian. Treatment of cardiac arrest in acute myocardial ischaemia and infarction. , 1961, Lancet.
[36] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[37] André Cournand,et al. Catheterization of the Right Auricle in Man , 1941 .
[38] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[39] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[40] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[41] Shih-Chieh Chang,et al. Images in clinical medicine. Acute mesenteric infarction associated with atrial fibrillation. , 2011, The New England journal of medicine.
[42] Holger Gerhardt,et al. Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.
[43] Robert M. Rapoport,et al. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.
[44] D. Scholtens,et al. The Hemostatic System as a Modulator of Atherosclerosis , 2011 .
[45] B. Gersh. Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease , 2011 .
[46] P. Libby,et al. Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.
[47] Paul Burton,et al. Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.
[48] J. Goldstein,et al. The LDL receptor. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[49] M. Silverman. William heberden and some account of a disorder of the breast , 1987, Clinical cardiology.
[50] HOMAS,et al. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .
[51] J. T. Wearn. THROMBOSIS OF THE CORONARY ARTERIES, WITH INFARCTION OF THE HEART , 1923 .
[52] M. Davies,et al. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. , 1976, British heart journal.
[53] G. Blaise. Endothelium derived relaxing factor/nitric oxide , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[54] E. Nabel,et al. Genomics of cardiovascular disease. , 2011, The New England journal of medicine.
[55] J. H. Gibbon,et al. Application of a mechanical heart and lung apparatus to cardiac surgery. , 1954, Minnesota medicine.
[56] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[57] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.
[58] P. Serruys,et al. Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial , 2002, Circulation.
[59] K. Musunuru,et al. Stem cell models of cardiac development and disease. , 2010, Annual review of cell and developmental biology.
[60] J. Goldstein,et al. A Receptor‐Mediated Pathway for Cholesterol Homeostasis (Nobel Lecture) , 1986 .
[61] Chazov Ei,et al. Intracoronary administration of fibrinolysin in acute myocardial infarct , 1976 .
[62] Werner Forssmann,et al. Die Sondierung des Rechten Herzens , 1929, Klinische Wochenschrift.
[63] F. Sones,et al. Cine-coronary arteriography. , 1962, The Ohio State medical journal.
[64] Barry Greenberg,et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.